Bio-Techne Income Statement (2009-2026) | TECH

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	259.03M	257.72M	269.28M	290.38M	288.23M	2.00M	271.58M	294.15M	301.32M	276.94M	272.60M	303.43M	306.10M	289.46M	297.03M	316.18M	316.96M	286.56M	295.88M	311.42M
Cost of Revenue (Quarter)	83.08M	86.72M	85.58M	88.92M	87.88M	90.06M	88.22M	91.98M	96.62M	91.74M	96.01M	98.83M	102.75M	106.44M	103.14M	101.62M	118.15M	98.44M	104.60M	103.13M
Gross Profit (Quarter)	175.94M	171.00M	183.69M	201.46M	200.35M	179.59M	183.36M	202.16M	204.70M	185.19M	176.59M	204.60M	203.35M	183.02M	193.89M	214.56M	198.81M	188.11M	191.28M	208.29M
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	20.72M	21.60M	20.65M	21.74M	23.15M	23.90M	22.46M	22.71M	23.42M	24.00M	22.92M	25.76M	23.99M	23.87M	25.02M	24.58M	26.03M	24.24M	23.12M	23.45M
Selling, General & Administrative (Quarter)	86.64M	86.17M	100.69M	89.27M	96.63M	99.38M	93.01M	99.24M	86.75M	105.33M	115.67M	111.84M	133.54M	119.16M	121.45M	151.27M	196.64M	116.21M	113.69M	109.34M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	107.36M	107.78M	121.34M	111.01M	119.78M	123.28M	115.47M	121.95M	110.17M	129.33M	138.58M	137.60M	157.53M	143.03M	146.47M	175.85M	222.67M	140.45M	136.82M	132.79M
Operating Income (Quarter)	68.58M	63.22M	62.35M	90.45M	80.57M	56.32M	67.89M	80.21M	94.53M	55.86M	38.00M	67.00M	45.82M	39.99M	47.42M	38.71M	-23.86M	47.66M	54.46M	75.50M
EBIT (Quarter)	68.58M	63.22M	62.35M	90.45M	80.57M	56.32M	67.89M	80.21M	94.53M	55.86M	38.00M	67.00M	45.82M	39.99M	47.42M	38.71M	-23.86M	47.66M	54.46M	75.50M
Non-operating items
Non Operating Investment Income (Quarter)						49.77M	-0.07M	0.31M	-0.68M	0.28M
Interest & Investment Income (Quarter)	0.17M	0.19M	0.24M	0.17M	0.19M	0.43M	0.97M	0.97M	1.03M	0.89M	0.82M	0.71M	0.91M	0.93M	1.35M	1.03M	0.58M	0.97M	0.90M	0.98M
Other Non Operating Income (Quarter)	-58.34M	7.38M	26.49M	-19.35M	0.80M	50.76M	-0.07M	0.38M	-3.54M
Non Operating Income (Quarter)	-58.34M	7.38M	23.83M	-19.35M	0.80M	47.40M	-1.46M	-0.01M	1.60M	-6.30M	-4.62M	-5.91M	8.25M	0.18M	-4.54M	-0.43M	1.00M	0.33M	-3.68M	-4.27M
Net income details
EBT (Quarter)	-45.40M	67.38M	86.18M	68.77M	-176.07M	103.72M	66.43M	80.20M	88.32M	49.56M	33.39M	61.08M	30.78M	40.17M	42.88M	38.27M	-109.67M	47.99M	50.78M	71.22M
Tax Provisions (Quarter)	20.48M	-1.60M	14.12M	8.63M	17.14M	13.98M	16.42M	9.98M	42.63M	-1.44M	5.92M	12.03M	1.07M	6.57M	7.99M	15.69M	-5.18M	9.81M	12.78M	20.18M
Profit After Tax (Quarter)	14.96M	68.98M	72.06M	60.74M	61.91M	89.73M	50.01M	70.22M	75.31M	50.99M	27.46M	49.06M	40.59M	33.60M	34.89M	22.59M	-17.68M	38.19M	38.01M	51.05M
Equity Income (Quarter)										-2.29M	-1.91M	-1.75M	-0.89M	0.37M	0.05M	-0.59M	1.11M	0.29M	0.11M	-0.74M
Income from Non-Controlling Interests (Quarter)	-0.32M	-0.63M	-8.11M	-0.59M	0.39M	0.18M
Income from Continuing Operations (Quarter)	-65.88M	68.98M	72.06M	60.14M	-193.20M	89.73M	50.01M	70.22M	45.69M	50.99M	27.46M	49.06M	29.70M	33.60M	34.89M	22.59M	-104.49M	38.19M	38.01M	51.05M
Consolidated Net Income (Quarter)	-65.88M	68.98M	72.06M	60.14M	-193.20M	89.73M	50.01M	70.22M	45.69M	50.99M	27.46M	49.06M	29.70M	33.60M	34.89M	22.59M	-104.49M	38.19M	38.01M	51.05M
Income towards Parent Company (Quarter)	-65.88M	68.98M	72.06M	60.14M	-193.20M	89.73M	50.01M	70.22M	45.69M	50.99M	27.46M	49.06M	29.70M	33.60M	34.89M	22.59M	-104.49M	38.19M	38.01M	51.05M
Net Income towards Common Stockholders (Quarter)	-65.88M	68.98M	72.06M	60.14M	-193.20M	89.73M	50.01M	70.22M	45.69M	50.99M	27.46M	49.06M	29.70M	33.60M	34.89M	22.59M	-104.49M	38.19M	38.01M	51.05M
Additional items
EPS (Basic) (Quarter)	-2.33	1.78	0.51	0.39	0.39	0.57	0.32	0.45	0.47	0.32	0.17	0.31	0.26	0.21	0.22	0.14	-0.11	0.25	0.24	0.33
EPS (Weighted Average and Diluted) (Quarter)	-2.24	1.69	0.49	0.37	0.38	0.55	0.31	0.43	0.46	0.31	0.17	0.31	0.26	0.21	0.22	0.14	-0.11	0.24	0.24	0.32
Shares Outstanding (Weighted Average) (Quarter)	154.99M	39.09M	39.31M	156.90M	156.87M	156.93M	157.01M	157.31M	157.18M	158.13M	157.53M	157.66M	157.71M	158.53M	158.48M	157.37M	157.52M	155.46M	155.84M	155.89M
Shares Outstanding (Diluted Average) (Quarter)	40.48M	41.16M	41.21M
EBITDA (Quarter)	21.69M	62.69M	84.92M	65.07M	41.47M	72.94M	66.69M	71.79M	82.97M	39.04M	41.82M	37.41M	37.58M	51.83M	9.33M	26.19M	4.49M	33.67M	40.06M	46.53M
Interest Expenses (Quarter)	3.29M	3.41M	2.90M	2.49M	2.50M	3.79M	2.36M	1.37M	3.70M	4.89M	4.33M	4.00M	2.51M	2.18M	2.15M	2.01M	2.18M	2.93M	2.17M	2.40M
Tax Rate (Quarter)	-45.11%	-2.37%	16.38%	12.55%	-9.73%	13.48%	24.72%	12.44%	48.27%	-2.90%	17.74%	19.69%	3.49%	16.36%	18.63%	40.98%	4.72%	20.43%	25.16%	28.33%

Research Tools

Bio-Techne Income Statement (2009-2026) | TECH

Create an account

Sign In

Reset Password